1. Product
Overview
1.1. Market
Definition
1.2. Scope
of the Market
1.2.1. Markets
Covered
1.2.2. Years
Considered for Study
1.2.3. Key
Market Segmentations
2. Research
Methodology
2.1. Objective
of the Study
2.2. Baseline
Methodology
2.3. Key
Industry Partners
2.4. Major
Association and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data
Triangulation & Validation
2.7. Assumptions
and Limitations
3. Executive
Summary
3.1. Overview
of the Market
3.2. Overview
of Key Market Segmentations
3.3. Overview
of Key Market Players
3.4. Overview
of Key Regions/Countries
3.5. Overview
of Market Drivers, Challenges, Trends
4. Voice
of Customer
5. Clinical
Trial Analysis
5.1. Ongoing
Clinical Trials
5.2. Completed
Clinical Trials
5.3. Terminated
Clinical Trials
5.4. Breakdown
of Pipeline, By Development Phase
5.5. Breakdown
of Pipeline, By Status
5.6. Breakdown
of Pipeline, By Study Application
5.7. Breakdown
of Pipeline, By Region
5.8. Clinical
Trials Heat Map
6. Global
ELISA Test Market Outlook
6.1. Market
Size & Forecast
6.1.1. By
Value
6.2. Market
Share & Forecast
6.2.1. By
Method (Direct ELISA, Indirect ELISA, Sandwich ELISA and Competitive ELISA)
6.2.2. By
Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug
Monitoring and Pharmaceutical Industry, Transplantation, Others (Infectious
Diseases, Cancer, Protein Quantitation)
6.2.3. By
Technology (Chemiluminescent, Colorimetric, Fluorescent)
6.2.4. By
End User (Hospitals, Diagnostic Centers, Research Laboratories, Others)
6.2.5. By
Company (2022)
6.2.6. By
Region
6.3. Market
Map
6.4.
7. Asia-Pacific
ELISA Test Market Outlook
7.1. Market
Size & Forecast
7.1.1. By
Value
7.2. Market
Share & Forecast
7.2.1.
By Method
7.2.2.
By Application
7.2.3.
By Technology
7.2.4.
By End User
7.2.5. By
Country
7.3. Asia-Pacific:
Country Analysis
7.3.1. China
ELISA Test Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Method
7.3.1.2.2.
By Application
7.3.1.2.3.
By Technology
7.3.1.2.4.
By End User
7.3.2. India
ELISA Test Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Method
7.3.2.2.2.
By Application
7.3.2.2.3.
By Technology
7.3.2.2.4.
By End User
7.3.3. Japan
ELISA Test Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Method
7.3.3.2.2.
By Application
7.3.3.2.3.
By Technology
7.3.3.2.4.
By End User
7.3.4. South
Korea ELISA Test Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Method
7.3.4.2.2.
By Application
7.3.4.2.3.
By Technology
7.3.4.2.4.
By End User
7.3.5. Australia
ELISA Test Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Method
7.3.5.2.2.
By Application
7.3.5.2.3.
By Technology
7.3.5.2.4.
By End User
8. Europe
ELISA Test Market Outlook
8.1. Market
Size & Forecast
8.1.1. By
Value
8.2. Market
Share & Forecast
8.2.1. By
Method
8.2.2. By
Application
8.2.3. By
Technology
8.2.4. By
End User
8.2.5. By
Country
8.3. Europe:
Country Analysis
8.3.1. France
ELISA Test Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Method
8.3.1.2.2.
By Application
8.3.1.2.3.
By Technology
8.3.1.2.4.
By End User
8.3.2. Germany
ELISA Test Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Method
8.3.2.2.2.
By Application
8.3.2.2.3.
By Technology
8.3.2.2.4.
By End User
8.3.3. United
Kingdom ELISA Test Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Method
8.3.3.2.2.
By Application
8.3.3.2.3.
By Technology
8.3.3.2.4.
By End User
8.3.4. Italy
ELISA Test Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Method
8.3.4.2.2.
By Application
8.3.4.2.3.
By Technology
8.3.4.2.4.
By End User
8.3.5. Spain
ELISA Test Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Method
8.3.5.2.2.
By Application
8.3.5.2.3.
By Technology
8.3.5.2.4.
By End User
9. North
America ELISA Test Market Outlook
9.1. Market
Size & Forecast
9.1.1. By
Value
9.2. Market
Share & Forecast
9.2.1. By
Method
9.2.2. By
Application
9.2.3. By
Technology
9.2.4. By
End User
9.2.5. By
Country
9.3. North
America: Country Analysis
9.3.1. United
States ELISA Test Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Method
9.3.1.2.2.
By Application
9.3.1.2.3.
By Technology
9.3.1.2.4.
By End User
9.3.2. Mexico
ELISA Test Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Method
9.3.2.2.2.
By Application
9.3.2.2.3.
By Technology
9.3.2.2.4.
By End User
9.3.3. Canada
ELISA Test Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Method
9.3.3.2.2.
By Application
9.3.3.2.3.
By Technology
9.3.3.2.4.
By End User
10. South
America ELISA Test Market Outlook
10.1.
Market Size & Forecast
10.1.1. By
Value
10.2.
Market Share & Forecast
10.2.1. By
Method
10.2.2. By
Application
10.2.3. By Technology
10.2.4. By
End User
10.2.5. By
Country
10.3.
South America: Country Analysis
10.3.1. Brazil
ELISA Test Market Outlook
10.3.1.1. Market
Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market
Share & Forecast
10.3.1.2.1.
By Method
10.3.1.2.2.
By Application
10.3.1.2.3.
By Technology
10.3.1.2.4.
By End User
10.3.2. Argentina
ELISA Test Market Outlook
10.3.2.1. Market
Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market
Share & Forecast
10.3.2.2.1.
By Method
10.3.2.2.2.
By Application
10.3.2.2.3.
By Technology
10.3.2.2.4.
By End User
10.3.3. Colombia
ELISA Test Market Outlook
10.3.3.1. Market
Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market
Share & Forecast
10.3.3.2.1.
By Method
10.3.3.2.2.
By Application
10.3.3.2.3.
By Technology
10.3.3.2.4.
By End User
11. Middle
East and Africa ELISA Test Market Outlook
11.1.
Market Size & Forecast
11.1.1. By
Value
11.2.
Market Share & Forecast
11.2.1. By
Method
11.2.2. By
Application
11.2.3. By
Technology
11.2.4. By
End User
11.2.5. By
Country
11.3.
MEA: Country Analysis
11.3.1. South
Africa ELISA Test Market Outlook
11.3.1.1. Market
Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market
Share & Forecast
11.3.1.2.1.
By Method
11.3.1.2.2.
By Application
11.3.1.2.3.
By Technology
11.3.1.2.4.
By End User
11.3.2. Saudi
Arabia ELISA Test Market Outlook
11.3.2.1. Market
Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market
Share & Forecast
11.3.2.2.1.
By Method
11.3.2.2.2.
By Application
11.3.2.2.3.
By Technology
11.3.2.2.4.
By End User
11.3.3. UAE
ELISA Test Market Outlook
11.3.3.1. Market
Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market
Share & Forecast
11.3.3.2.1.
By Method
11.3.3.2.2.
By Application
11.3.3.2.3.
By Technology
11.3.3.2.4.
By End User
12. Market
Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market
Trends & Developments
13.1.
Recent Developments
13.2.
Mergers & Acquisitions
13.3.
Product Developments
14. Competitive
Landscape
14.1.
Business Overview
14.2.
Company Snapshot
14.3.
Products & Services
14.4.
Financials (In case of listed companies)
14.5.
Recent Developments
14.6.
SWOT Analysis
14.6.1. F.
Hoffmann-La Roche Ltd.
14.6.2. Thermo
Fisher Scientific Inc.
14.6.3. Becton,
Dickinson and Company
14.6.4. Bio-Rad
Laboratories, Inc.
14.6.5. bioMérieux
SA
14.6.6. Enzo
Life Sciences, Inc.
14.6.7. BioLegend,
Inc.
14.6.8. ELISA
Technologies, Inc.
14.6.9. RayBiotech,
Inc.
14.6.10.
Eurofins Scientific Ltd.
15. Strategic Recommendations